Skip to main content

Table 5 Concordance indices of the current three-strata risk group model (NICE) and Cambridge Prognostic Group (CPG) from competing risk analysis in predicting prostate cancer-specific mortality stratified by each treatment group (p < 0.0001 for all comparisons)

From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Cohort (n) Concordance index (confidence interval)
NICE CPG
Prostatectomy (20,586) 0.74 (0.72–0.77) 0.77 (0.74–0.79)
Radiotherapy (11,872) 0.69 (0.67–0.70) 0.73 (0.71–0.75)
Conservative management (11,757) 0.73 (0.71–0.74) 0.74 (0.73–0.76)